GlassScriptPhysician profile
Abdi Rasekh
NPI 1376645515
$74,719.95
in general payments reported to CMS, 2019-2025
33 companies · $14K in 2025
The $14K reported for 2025 was more than what 85% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20K · 2020: $4,031 · 2021: $7,915 · 2022: $7,488 · 2023: $18K · 2024: $3,536 · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $13K · Food and Beverage: $12K · Travel and Lodging: $7,206 · Consulting Fee: $3,300.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $13,000.00 |
| Food and Beverage | $11,984.12 |
| Travel and Lodging | $7,205.91 |
| Consulting Fee | $3,300.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $18,890.18 | 2019-2025 | Lariat Rs, Epi-Sense Guided Coagulation System With Visitrax, Epi-Ease Epicardial Access System |
| Boston Scientific Corporation | $15,978.97 | 2019-2025 | Rhythmia Mapping System, Versacross Access Solution, Farapulse |
| Abbott Laboratories | $12,370.63 | 2019-2025 | Aveir, Ensite Precision, Ensite |
| Medtronic, INC. | $11,887.75 | 2021-2025 | Evera Mri Xt Dr Surescan, Na, Pulseselect |
| Biosense Webster, INC. | $7,940.49 | 2019-2025 | Carto 3, Thermocool Sf, Visitag Surpoint External Processing Unit |
| Baylis Medical Company INC | $1,640.00 | 2019 | |
| Medical Device Business Services, INC. | $1,350.00 | 2023 | Carto 3 |
| Impulse Dynamics (USA) INC. | $1,105.54 | 2021-2025 | Optimizer, Optimizer |
| Cardiofocus, INC. | $851.48 | 2020-2022 | |
| Cvrx, INC. | $537.27 | 2021-2022 | |
| Cardiva Medical, INC. | $488.48 | 2019-2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Medtronic Vascular, INC. | $461.22 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $203.13 | 2021-2025 | Eliquis, Camzyos |
| Pfizer INC. | $173.16 | 2019-2023 | |
| Novartis Pharmaceuticals Corporation | $150.46 | 2019-2023 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $132.28 | 2020-2025 | |
| Zoll Respicardia, INC. | $119.63 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $67.42 | 2020-2021 | |
| Irhythm Technologies, INC. | $56.28 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Elutia, INC. | $54.54 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $44.25 | 2022 | |
| Sanofi-Aventis U.S. LLC | $38.64 | 2022 | |
| Bridgebio Pharma, INC. | $26.29 | 2025 | Attruby |
| Amarin Pharma, INC. | $23.07 | 2022 | |
| Circa Scientific, INC. | $20.34 | 2025 | |
| Novo Nordisk INC | $16.78 | 2022 | |
| Esperion Therapeutics, INC. | $16.44 | 2023 | Nexletol |
| Amgen INC. | $16.22 | 2022 | |
| Itamar Medical INC | $15.93 | 2022 | |
| Lexicon Pharmaceuticals, INC. | $15.73 | 2023 | Inpefa |
| Chiesi USA, INC. | $15.14 | 2020 | |
| Biotronik INC. | $12.21 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abdi Rasekh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.